CymitQuimica logo

Plerixafor-d4

CAS:

Ref. TR-P580502

1mg
251.00€
10mg
1,685.00€
Plerixafor-d4
TRC

Product Information

Name:Plerixafor-d4
Controlled Product
Synonyms:
  • 1,1'-[1,4-(Phenylene-d4)bis(methylene)]bis-1,4,8,11-tetraazacyclotetradecane
Brand:TRC
Description:Stability Very HygroscopicApplications Labelled Plerixafor, it is a hematopoietic stem cell (HSC) mobilizer that inhibits the CXCR4 chemokine receptor and blocks binding of its ligand, stromal cell-derived factor-1-α (SDF-1-α). This agent was approved on Dec. 15, 2008, as treatment in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize HSCs to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma (NHL) and multiple myeloma (MM).References Xie, T., et al.: Science, 290, 328 (2000), Leone, D., et al.: J. Pharmacol. Exp. Ther., 305, 1150 (2003), Chigaev, A., et al.: J. Immunol. 178, 6828 (2007), Kiel, M., et al.: Cell Stem Cell, 1, 204 (2007),
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:506.81
Formula:C28H50D4N8
Color/Form:Off White Solid
InChI:InChI=1S/C28H54N8/c1-9-29-15-17-31-13-3-21-35(23-19-33-11-1)25-27-5-7-28(8-6-27)26-36-22-4-14-32-18-16-30-10-2-12-34-20-24-36/h5-8,29-34H,1-4,9-26H2/i5D,6D,7D,8D
InChI key:InChIKey=YIQPUIGJQJDJOS-KDWZCNHSSA-N
SMILES:[2H]c1c([2H])c(CN2CCCNCCNCCCNCC2)c([2H])c([2H])c1CN1CCCNCCNCCCNCC1

Technical inquiry about: Plerixafor-d4

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.